$CCRD
CoreCard Corp

2023 Q1 Form 10-K Financial Statement

#000143774923005161 Filed on March 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $14.76M $15.83M $69.77M
YoY Change -39.24% 21.3% 44.6%
Cost Of Revenue $9.804M $8.656M $32.66M
YoY Change 31.49% 31.43% 42.63%
Gross Profit $4.952M $7.169M $37.10M
YoY Change -70.57% 10.98% 46.38%
Gross Profit Margin 33.56% 45.3% 53.18%
Selling, General & Admin $1.618M $1.353M $5.448M
YoY Change -7.6% -21.75% 12.82%
% of Gross Profit 32.67% 18.87% 14.68%
Research & Development $1.514M $2.784M $11.70M
YoY Change -54.45% 63.19% 32.07%
% of Gross Profit 30.57% 38.83% 31.54%
Depreciation & Amortization $1.695M $2.061M $5.697M
YoY Change 27.64% 87.53% 50.08%
% of Gross Profit 34.23% 28.75% 15.36%
Operating Expenses $3.132M $4.137M $17.15M
YoY Change -38.29% 20.44% 25.28%
Operating Profit $1.820M $3.032M $19.95M
YoY Change -84.51% 0.23% 71.15%
Interest Expense -$295.0M $110.0K $306.0K
YoY Change 286307.77%
% of Operating Profit -16208.79% 3.63% 1.53%
Other Income/Expense, Net $90.00K $100.0K $226.0K
YoY Change 143.24% 112.77% -18.41%
Pretax Income $1.669M $1.792M $19.04M
YoY Change -85.72% -42.47% 61.82%
Income Tax $413.0K $796.0K $5.154M
% Of Pretax Income 24.75% 44.42% 27.08%
Net Earnings $1.256M $996.0K $13.88M
YoY Change -85.51% -62.56% 53.57%
Net Earnings / Revenue 8.51% 6.29% 19.9%
Basic Earnings Per Share $0.15 $1.62
Diluted Earnings Per Share $0.15 $0.12 $1.61
COMMON SHARES
Basic Shares Outstanding 8.503M 8.513M 8.574M
Diluted Shares Outstanding 8.532M 8.599M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.75M $25.37M $25.37M
YoY Change 8.97% -13.24% -13.24%
Cash & Equivalents $21.69M $20.40M
Short-Term Investments $5.054M $4.973M $4.973M
Other Short-Term Assets $3.449M $3.729M $3.729M
YoY Change 5.47% 82.26% 104.22%
Inventory
Prepaid Expenses
Receivables $14.01M $13.22M $13.22M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $44.21M $42.32M $42.32M
YoY Change -4.06% 14.89% 14.89%
LONG-TERM ASSETS
Property, Plant & Equipment $12.06M $12.01M $15.38M
YoY Change -3.21% 15.77% 7.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.885M $4.180M $5.180M
YoY Change 2.05% 15.63% -18.49%
Other Assets $3.422M $3.725M $185.0K
YoY Change -30.18% -18.76% -61.7%
Total Long-Term Assets $20.36M $20.91M $20.91M
YoY Change -13.75% -1.88% -1.88%
TOTAL ASSETS
Total Short-Term Assets $44.21M $42.32M $42.32M
Total Long-Term Assets $20.36M $20.91M $20.91M
Total Assets $64.57M $63.23M $63.23M
YoY Change -7.34% 8.74% 8.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.592M $2.011M $2.011M
YoY Change -61.85% -27.22% -27.22%
Accrued Expenses $826.0K $525.0K $2.413M
YoY Change 29.47% 29.95% -5.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.968M $7.543M $7.543M
YoY Change -48.87% -30.5% -30.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.154M $2.454M $2.454M
YoY Change -35.22% -14.55% -14.55%
Total Long-Term Liabilities $2.599M $2.926M $2.454M
YoY Change -33.03% -14.47% -14.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.968M $7.543M $7.543M
Total Long-Term Liabilities $2.599M $2.926M $2.454M
Total Liabilities $10.57M $10.47M $10.47M
YoY Change -45.71% -26.66% -26.66%
SHAREHOLDERS EQUITY
Retained Earnings $54.18M $52.93M
YoY Change 13.55% 35.55%
Common Stock $16.56M $16.56M
YoY Change 1.22% 1.28%
Preferred Stock
YoY Change
Treasury Stock (at cost) $16.66M
YoY Change 47.1%
Treasury Stock Shares $507.4K
Shareholders Equity $54.00M $52.76M $52.76M
YoY Change
Total Liabilities & Shareholders Equity $64.57M $63.23M $63.23M
YoY Change -7.34% 8.74% 8.74%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $1.256M $996.0K $13.88M
YoY Change -85.51% -62.56% 53.57%
Depreciation, Depletion And Amortization $1.695M $2.061M $5.697M
YoY Change 27.64% 87.53% 50.08%
Cash From Operating Activities $2.948M -$993.0K $9.864M
YoY Change 841.85% -108.23% 10.64%
INVESTING ACTIVITIES
Capital Expenditures $1.628M $1.203M $8.735M
YoY Change -40.52% -154.88% 61.01%
Acquisitions
YoY Change
Other Investing Activities $26.00K -$3.926M -$4.749M
YoY Change -52.73% 440.03% 119.15%
Cash From Investing Activities -$1.602M -$5.129M -$13.48M
YoY Change -40.27% 75.71% 68.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.335M
YoY Change -44.93%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -293.0K -$5.335M
YoY Change -100.0% -31.38% -44.32%
NET CHANGE
Cash From Operating Activities $2.948M -993.0K $9.864M
Cash From Investing Activities -$1.602M -5.129M -$13.48M
Cash From Financing Activities 0.000 -293.0K -$5.335M
Net Change In Cash $1.293M -6.415M -$8.845M
YoY Change -127.51% -173.52% 1.53%
FREE CASH FLOW
Cash From Operating Activities $2.948M -$993.0K $9.864M
Capital Expenditures $1.628M $1.203M $8.735M
Free Cash Flow $1.320M -$2.196M $1.129M
YoY Change -154.46% -115.4% -67.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000320340
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 usd
CY2022 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2021 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
0 usd
CY2022 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
0 usd
CY2022Q4 ccrd Ownership Percentage
OwnershipPercentage
0.28 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
176571200 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8502735
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-61000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-194000 usd
CY2022 dei Auditor Firm
AuditorFirmId
281
CY2022 dei Auditor Name
AuditorName
Nichols, Cauley and Associates, LLC
CY2022 dei Auditor Location
AuditorLocation
Atlanta, Georgia
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20399000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29244000 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4973000 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13220000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5547000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3729000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2046000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
42321000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
36837000 usd
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
5180000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
6355000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12006000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10371000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3725000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4585000 usd
CY2022Q4 us-gaap Assets
Assets
63232000 usd
CY2021Q4 us-gaap Assets
Assets
58148000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2011000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2763000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1094000 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2263000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1888000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2145000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
525000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
404000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1004000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2025000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2274000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7543000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10853000 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
473000 usd
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
164000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
472000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
549000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1981000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2708000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2926000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3421000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9010119
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9001311
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8502735
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8689815
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
90000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
52925000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39044000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
52763000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
43874000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63232000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58148000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
69765000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
90000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16471000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16261000 usd
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
507384
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
311496
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
16662000 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
11327000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
226000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4550000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11700000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8859000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
19953000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
11658000 usd
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
-1144000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
277000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5112000 usd
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
-172000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19035000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11763000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5154000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2724000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
13881000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
9039000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.61
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8574019
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8777066
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8598546
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8809603
CY2022 us-gaap Net Income Loss
NetIncomeLoss
13881000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
9039000 usd
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
23000 usd
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
110000 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-54000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14014000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8985000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44151000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
108000 usd
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9688000 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
318000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-54000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
43874000 usd
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5335000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
13881000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
210000 usd
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
23000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
110000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
52763000 usd
CY2022Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
18338000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
13881000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
9039000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5697000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3796000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
210000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
319000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-77000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-227000 usd
CY2022 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
1450000 usd
CY2021 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2022 ccrd Noncash Interest Income
NoncashInterestIncome
55000 usd
CY2021 ccrd Noncash Interest Income
NoncashInterestIncome
-0 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
275000 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-172000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7673000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2277000 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1756000 usd
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
730000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
25000 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
61000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
751000 usd
CY2022 ccrd Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
309000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
321000 usd
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-257000 usd
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
244000 usd
CY2022 ccrd Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
-1169000 usd
CY2021 ccrd Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
941000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
121000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
83000 usd
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1268000 usd
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-2869000 usd
CY2021 ccrd Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
164000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9864000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8915000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8735000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5425000 usd
CY2022 ccrd Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
-0 usd
CY2021 ccrd Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
550000 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
400000 usd
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
-0 usd
CY2022 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
220000 usd
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
6944000 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1975000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13484000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
107000 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9688000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9581000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-54000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8712000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
29244000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2767000 usd
CY2021 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
1728000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<i>Use of Estimates </i>– In preparing the financial statements in conformity with accounting principles generally accepted in the United States, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. Areas where we use estimates and make assumptions are to determine our allowance for doubtful accounts, valuation of our investments, depreciation and amortization expense, accrued expenses and deferred income taxes.
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0 pure
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26284000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19339000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14278000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8968000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12006000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10371000 usd
CY2022Q4 us-gaap Investments
Investments
5180000 usd
CY2021Q4 us-gaap Investments
Investments
6355000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
22469000 usd
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
26866000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
210000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
319000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
69765000 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48248000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
69765000 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48248000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
4180000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3615000 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
275000 usd
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
-172000 usd
CY2018Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
250000 usd
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
0 usd
CY2020Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
750000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.271 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.232 pure
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1594000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1602000 usd
CY2022Q4 ccrd Debt Securities Availableforsale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Three
DebtSecuritiesAvailableforsaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree
3356000 usd
CY2022Q4 ccrd Debt Securities Availablefor Sale Maturity Allocated And Single Maturity Date Rolling After One Through Three Years Fair Value
DebtSecuritiesAvailableforSaleMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughThreeYearsFairValue
3371000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4950000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4973000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
5231000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2951000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-77000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-227000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5154000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2724000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.047 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.058 pure
CY2022 ccrd Effective Income Tax Rate Reconciliation Equity Compensation Percent
EffectiveIncomeTaxRateReconciliationEquityCompensationPercent
0 pure
CY2021 ccrd Effective Income Tax Rate Reconciliation Equity Compensation Percent
EffectiveIncomeTaxRateReconciliationEquityCompensationPercent
0.003 pure
CY2022 ccrd Effective Income Tax Rate Reconciliation Tax Credit Research And Development Percent
EffectiveIncomeTaxRateReconciliationTaxCreditResearchAndDevelopmentPercent
0.015 pure
CY2021 ccrd Effective Income Tax Rate Reconciliation Tax Credit Research And Development Percent
EffectiveIncomeTaxRateReconciliationTaxCreditResearchAndDevelopmentPercent
0.026 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
0.013 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
0.013 pure
CY2022 ccrd Effective Income Tax Rate Reconciliation Global Intangible Low Taxed Income Inclusion Percent
EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeInclusionPercent
0.039 pure
CY2021 ccrd Effective Income Tax Rate Reconciliation Global Intangible Low Taxed Income Inclusion Percent
EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxedIncomeInclusionPercent
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003 pure
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
788000 usd
CY2021Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
896000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
822000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
259000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1441000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1335000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
124000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-148000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
45000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
32000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
517000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
517000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
472000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
549000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
500000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
500000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
500000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
500000 usd
CY2022Q4 ccrd Operating Lease Rightofuse Asset And Lease Liability
OperatingLeaseRightofuseAssetAndLeaseLiability
3373000 usd
CY2021Q4 ccrd Operating Lease Rightofuse Asset And Lease Liability
OperatingLeaseRightofuseAssetAndLeaseLiability
3955000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1323000 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1239000 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.034 pure
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.041 pure
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1315000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
993000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
603000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
490000 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
1323000 usd
CY2022Q4 ccrd Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
68000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3469000 usd
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.59
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
67500
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
17.35
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
59000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
59000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
932369
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
881177
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
59000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
1239000 usd
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
67000 usd
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
58000 usd
CY2022Q4 ccrd Related Party Ownership Percentage
RelatedPartyOwnershipPercentage
1 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
59000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
59000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
126500
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
49000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.81
CY2021Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
17.35
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
17.35
CY2022 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
3.50
CY2022 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
39.11
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
59000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.35
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
766630 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13881000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9039000 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8574000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8777000
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
25000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
33000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8599000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8810000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.61
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
25000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
33000

Files In Submission

Name View Source Status
0001437749-23-005161-index-headers.html Edgar Link pending
0001437749-23-005161-index.html Edgar Link pending
0001437749-23-005161.txt Edgar Link pending
0001437749-23-005161-xbrl.zip Edgar Link pending
ccrd-20221231.xsd Edgar Link pending
ex_479961.htm Edgar Link pending
ex_479962.htm Edgar Link pending
ex_479963.htm Edgar Link pending
ex_479964.htm Edgar Link pending
ex_479965.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ins20221231_10k.htm Edgar Link pending
logo.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
ccrd-20221231_cal.xml Edgar Link unprocessable
ccrd-20221231_def.xml Edgar Link unprocessable
ccrd-20221231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ccrd-20221231_pre.xml Edgar Link unprocessable
ins20221231_10k_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending